SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: yosid who wrote (716)10/12/1998 5:18:00 PM
From: John Binford, Jr.  Read Replies (1) of 1754
 
Shorting any stock last Monday would have worked. Visx has held up as well or better than the other laser vision stocks (compare percentage drops.)

As for what price is justified if Visx turns out $.60/sh, I don't know. If we take $.60/sh * 4 = $2.40/sh, then $60 is 25 times earnings. If the stock is growing at > 30% per year (recently it has been growing at 100% per year) then maybe it should have a P/E of 30 or more, which would result in $72/sh. So my rule of thumb is to take the fully taxed operating earnings and multiply by 100 to 120 for a reasonable price level.

Analysts have 6 to 9 month targets around $80 to $85/sh.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext